A	O
chimeric	B-protein
type	I-protein
II/type	I-protein
I	I-protein
interleukin-1	I-protein
receptor	I-protein
can	O
mediate	O
interleukin-1	B-protein
induction	O
of	O
gene	O
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
type	B-protein
I	I-protein
interleukin-1	I-protein
receptor	I-protein
(	O
IL-1R	B-protein
)	O
is	O
capable	O
of	O
transducing	O
a	O
signal	O
resulting	O
in	O
promoter	O
activation	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

This	O
signal	O
transduction	O
is	O
dependent	O
on	O
the	O
cytoplasmic	B-protein
domain	I-protein
,	O
which	O
consists	O
of	O
213	O
amino	O
acids	O
.	O

In	O
contrast	O
to	O
the	O
type	B-protein
I	I-protein
receptor	I-protein
,	O
the	O
type	B-protein
II	I-protein
IL-1R	I-protein
has	O
a	O
small	O
cytoplasmic	B-protein
tail	I-protein
,	O
and	O
it	O
is	O
not	O
clear	O
whether	O
this	O
receptor	O
is	O
a	O
signal-transducing	B-protein
or	O
a	O
regulatory	B-protein
molecule	I-protein
.	O

Here	O
we	O
report	O
that	O
the	O
type	B-protein
II	I-protein
IL-1R	I-protein
does	O
not	O
mediate	O
gene	O
activation	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

However	O
,	O
a	O
hybrid	O
receptor	O
composed	O
of	O
the	O
extracellular	B-protein
and	I-protein
transmembrane	I-protein
regions	I-protein
of	O
the	O
human	B-protein
type	I-protein
II	I-protein
interleukin-1	I-protein
fused	O
to	O
the	O
cytoplasmic	B-protein
domain	I-protein
of	O
the	O
human	B-protein
type	I-protein
I	I-protein
IL-1R	I-protein
was	O
capable	O
of	O
transducing	O
a	O
signal	O
across	O
the	O
membrane	O
resulting	O
in	O
a	O
pattern	O
of	O
gene	O
activation	O
identical	O
to	O
that	O
mediated	O
by	O
the	O
type	B-protein
I	I-protein
IL-1R	I-protein
.	O

Our	O
results	O
indicated	O
that	O
the	O
extracellular	B-protein
domain	I-protein
of	O
the	O
type	B-protein
II	I-protein
IL-1R	I-protein
was	O
capable	O
of	O
functionally	O
interacting	O
with	O
interleukin-1	B-protein
and	O
transmitting	O
the	O
resulting	O
signal	O
to	O
a	O
heterologous	B-protein
cytoplasmic	I-protein
domain	I-protein
.	O

THE	NULL
JourNAL	NULL
or	NULL
B1OLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

14	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

10490-10494	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.9.A	NULL
.	NULL

A	NULL
Chimeric	NULL
Type	NULL
II/Type	NULL
I	NULL
Interleukin-1	NULL
Receptor	NULL
Can	NULL
Mediate	NULL
Interleukin-1	NULL
Induction	NULL
of	NULL
Gene	NULL
Expression	NULL
in	NULL
T	NULL
Cells®	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
20	NULL
,	NULL
1992	NULL
)	NULL
Adriana	NULL
Heguyt	NULL
,	NULL
Cosima	NULL
T.	NULL
Baldari§	NULL
,	NULL
Stefano	NULL
Censinit	NULL
,	NULL
Paolo	NULL
Ghiarat	NULL
,	NULL
and	NULL
John	NULL
L.	NULL
Telford	NULL
}	NULL
!	NULL

From	NULL
the	NULL
{	NULL
Immunological	NULL
Research	NULL
Institute	NULL
Siena	NULL
(	NULL
IRIS	NULL
)	NULL
,	NULL
Via	NULL
Fiorentina	NULL
1	NULL
,	NULL
53100	NULL
Siena	NULL
,	NULL
Italy	NULL
and	NULL
the	NULL
§Department	NULL
of	NULL
Evolutionary	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Siena	NULL
,	NULL
53100	NULL
Siena	NULL
,	NULL
Italy	NULL
The	NULL
type	NULL
I	NULL
interleukin-1	NULL
receptor	NULL
(	NULL
IL-1R	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
transducing	NULL
a	NULL
signal	NULL
resulting	NULL
in	NULL
promoter	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
signal	NULL
transduction	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
213	NULL
amino	NULL
acids	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
type	NULL
I	NULL
receptor	NULL
,	NULL
the	NULL
type	NULL
II	NULL
IL-	NULL
1R	NULL
has	NULL
a	NULL
small	NULL
cytoplasmic	NULL
tail	NULL
,	NULL
and	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
this	NULL
receptor	NULL
is	NULL
a	NULL
signal-transducing	NULL
or	NULL
a	NULL
regulatory	NULL
molecule	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
does	NULL
not	NULL
mediate	NULL
gene	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
a	NULL
hybrid	NULL
receptor	NULL
composed	NULL
of	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
type	NULL
II	NULL
interleukin-1	NULL
fused	NULL
to	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
was	NULL
capable	NULL
of	NULL
transducing	NULL
a	NULL
signal	NULL
across	NULL
the	NULL
membrane	NULL
resulting	NULL
in	NULL
a	NULL
pattern	NULL
of	NULL
gene	NULL
activation	NULL
identical	NULL
to	NULL
that	NULL
mediated	NULL
by	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
.	NULL

Our	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1	NULL
R	NULL
was	NULL
capable	NULL
of	NULL
functionally	NULL
interacting	NULL
with	NULL
interleukin-1	NULL
and	NULL
transmitting	NULL
the	NULL
resulting	NULL
signal	NULL
to	NULL
a	NULL
heterologous	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
ligands	NULL
with	NULL
cell	NULL
surface	NULL
receptors	NULL
is	NULL
a	NULL
key	NULL
event	NULL
in	NULL
extracellularly	NULL
induced	NULL
processes	NULL
leading	NULL
to	NULL
cell	NULL
differentiation	NULL
and	NULL
proliferation	NULL
.	NULL

Much	NULL
attention	NULL
has	NULL
been	NULL
given	NULL
to	NULL
the	NULL
intracellular	NULL
interactions	NULL
that	NULL
occur	NULL
after	NULL
receptor	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
and	NULL
interaction	NULL
with	NULL
second	NULL
messengers	NULL
,	NULL
but	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
ligand	NULL
binding	NULL
causes	NULL
transduction	NULL
of	NULL
a	NULL
signal	NULL
between	NULL
an	NULL
extracellular	NULL
domain	NULL
and	NULL
an	NULL
intracellular	NULL
domain	NULL
separated	NULL
by	NULL
the	NULL
plasma	NULL
membrane	NULL
are	NULL
still	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
receptor	NULL
dimerization	NULL
upon	NULL
ligand	NULL
binding	NULL
is	NULL
a	NULL
key	NULL
event	NULL
(	NULL
Ullrich	NULL
and	NULL
Schlessinger	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
physical	NULL
proximity	NULL
of	NULL
two	NULL
intracellular	NULL
domains	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
formation	NULL
of	NULL
a	NULL
signaling	NULL
complex	NULL
.	NULL

Several	NULL
other	NULL
receptors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
and	NULL
hemato-poietic	NULL
growth	NULL
factor	NULL
receptors	NULL
,	NULL
have	NULL
very	NULL
short	NULL
intracellular	NULL
domains	NULL
and	NULL
need	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
second	NULL
chain	NULL
for	NULL
functional	NULL
signaling	NULL
(	NULL
Hatekayama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989a	NULL
,	NULL
1989b	NULL
;	NULL
Nicola	NULL
and	NULL
Metcalf	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Ligand	NULL
binding	NULL
is	NULL
not	NULL
always	NULL
sufficient	NULL
to	NULL
trigger	NULL
signal	NULL
transduction	NULL
.	NULL

The	NULL
IL-1	NULL
'	NULL
family	NULL
of	NULL
cytokines	NULL
comprises	NULL
three	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

TTo	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
39-577-293470	NULL
;	NULL
Fax	NULL
:	NULL
39-577-293564	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-1	NULL
,	NULL
interleukin-1	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
IL-1R	NULL
,	NULL
interleukin-1	NULL
receptor	NULL
;	NULL
hIL-1R	NULL
,	NULL
human	NULL
interleukin-1	NULL
receptor	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
;	NULL
IL-2R	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
IL-1ra	NULL
,	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

polypeptides	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
receptors	NULL
,	NULL
but	NULL
while	NULL
IL-la	NULL
and	NULL
IL-18	NULL
elicit	NULL
essentially	NULL
identical	NULL
biological	NULL
responses	NULL
,	NULL
the	NULL
IL-1lra	NULL
is	NULL
a	NULL
true	NULL
natural	NULL
antagonist	NULL
,	NULL
blocking	NULL
IL-la	NULL
and	NULL
IL-1	NULL
}	NULL
binding	NULL
without	NULL
triggering	NULL
IL-1R	NULL
signaling	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Dinarello	NULL
and	NULL
Thompson	NULL
(	NULL
1991	NULL
)	NULL
and	NULL
Dinarello	NULL
{	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
types	NULL
of	NULL
IL-1Rs	NULL
:	NULL
the	NULL
80-kDa	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
found	NULL
predominantly	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
fibroblasts	NULL
,	NULL
and	NULL
the	NULL
68-kDa	NULL
type	NULL
II	NULL
or	NULL
B	NULL
cell	NULL
IL-1R	NULL
,	NULL
also	NULL
found	NULL
in	NULL
monocytes	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
bone	NULL
marrow	NULL
cells	NULL
(	NULL
McMahan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
two	NULL
receptors	NULL
are	NULL
structurally	NULL
related	NULL
in	NULL
their	NULL
extracellular	NULL
domain	NULL
and	NULL
they	NULL
both	NULL
have	NULL
a	NULL
single	NULL
membrane-spanning	NULL
region	NULL
,	NULL
they	NULL
belong	NULL
to	NULL
different	NULL
categories	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
cytoplasmic	NULL
portions	NULL
(	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
,	NULL
1989	NULL
;	NULL
McMahan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
type	NULL
I	NULL
IL-1R	NULL
has	NULL
a	NULL
large	NULL
cytoplasmic	NULL
tail	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
signal	NULL
transduction	NULL
(	NULL
Curtis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Key	NULL
amino	NULL
acids	NULL
involved	NULL
in	NULL
type	NULL
I	NULL
IL-1R	NULL
function	NULL
have	NULL
been	NULL
defined	NULL
by	NULL
homology	NULL
with	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
Drosophila	NULL
morphogen	NULL
receptor	NULL
Toll	NULL
(	NULL
Gay	NULL
and	NULL
Keith	NULL
,	NULL
1991	NULL
;	NULL
Schneider	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
mutational	NULL
analysis	NULL
of	NULL
conserved	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
cytoplasmic	NULL
portion	NULL
(	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
type	NULL
I	NULL
receptor	NULL
,	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
has	NULL
a	NULL
very	NULL
short	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
29	NULL
amino	NULL
acids	NULL
(	NULL
McMahan	NULL
et	NULL
el	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
highly	NULL
unlikely	NULL
that	NULL
it	NULL
is	NULL
capable	NULL
of	NULL
transducing	NULL
a	NULL
signal	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
second	NULL
chain	NULL
.	NULL

IL-1	NULL
induces	NULL
biological	NULL
responses	NULL
in	NULL
cell	NULL
lines	NULL
that	NULL
apparently	NULL
express	NULL
only	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
receptor	NULL
must	NULL
be	NULL
capable	NULL
of	NULL
signaling	NULL
(	NULL
Giri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Horuk	NULL
and	NULL
McCubrey	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biological	NULL
relevance	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

Although	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
the	NULL
type	NULL
II	NULL
and	NULL
type	NULL
I	NULL
IL-1Rs	NULL
differ	NULL
,	NULL
the	NULL
homology	NULL
between	NULL
their	NULL
extracellular	NULL
domains	NULL
suggests	NULL
that	NULL
if	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
is	NULL
indeed	NULL
capable	NULL
of	NULL
transmitting	NULL
the	NULL
IL-1	NULL
signal	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
it	NULL
will	NULL
do	NULL
so	NULL
by	NULL
a	NULL
mechanism	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
chimeric	NULL
IL-1R	NULL
consisting	NULL
of	NULL
the	NULL
type	NULL
II	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
domains	NULL
fused	NULL
to	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
.	NULL

We	NULL
assayed	NULL
this	NULL
chimeric	NULL
receptor	NULL
in	NULL
a	NULL
system	NULL
that	NULL
we	NULL
previously	NULL
used	NULL
to	NULL
investigate	NULL
type	NULL
I	NULL
IL-1R	NULL
signal	NULL
transduction	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
extracellular	NULL
domain	NULL
is	NULL
capable	NULL
of	NULL
a	NULL
functional	NULL
interaction	NULL
with	NULL
IL-1	NULL
and	NULL
of	NULL
activating	NULL
the	NULL
heter-ologous	NULL
,	NULL
type	NULL
I	NULL
IL-1R	NULL
intracellular	NULL
domain	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Reagents-Recombinant	NULL
human	NULL
IL-18	NULL
from	NULL
Escherichia	NULL
coli	NULL
(	NULL
Cas-agli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
was	NULL
used	NULL
at	NULL
50	NULL
pM	NULL
unless	NULL
otherwise	NULL
stated	NULL
.	NULL

The	NULL
human	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
was	NULL
obtained	NULL
from	NULL
British	NULL
Biotechnology	NULL
.	NULL

Phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
at	NULL
1	NULL
mg/ml	NULL
and	NULL
used	NULL
at	NULL
10	NULL
ng/ml	NULL
for	NULL
stimulations	NULL
.	NULL

Phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
(	NULL
Wellcome	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
at	NULL
1	NULL
mg/ml	NULL
and	NULL
used	NULL
at	NULL
2	NULL
ug/ml	NULL
.	NULL

Acetyl	NULL
10490	NULL
Chimeric	NULL
Interleukin-1	NULL
Receptor	NULL
Signal	NULL
Transduction	NULL
coenzyme	NULL
A	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
and	NULL
[	NULL
``	NULL
*C	NULL
)	NULL
]	NULL
chloramphenicol	NULL
from	NULL
Amersham	NULL
International	NULL
were	NULL
used	NULL
for	NULL
the	NULL
CAT	NULL
assays	NULL
.	NULL

Protein	NULL
determinations	NULL
were	NULL
done	NULL
using	NULL
the	NULL
BCA	NULL
kit	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
)	NULL
.	NULL

Restriction	NULL
and	NULL
modification	NULL
enzymes	NULL
were	NULL
purchased	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
or	NULL
Promega	NULL
Corp.	NULL
and	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Polymerase	NULL
chain	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
Gene-Amp	NULL
kit	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
Instruments	NULL
)	NULL
or	NULL
vent	NULL
DNA	NULL
polymerase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
in	NULL
a	NULL
DNA	NULL
thermal	NULL
cycler	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
Instruments	NULL
)	NULL
.	NULL

Oligonucle-otides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
using	NULL
cyanoethyl	NULL
phosphoramidate	NULL
chemistry	NULL
.	NULL

For	NULL
nucleotide	NULL
sequence	NULL
determinations	NULL
,	NULL
we	NULL
used	NULL
the	NULL
Sequenase	NULL
kit	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

Plasmids-IL-2	NULL
CAT	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
pBluescript	NULL
SK+	NULL
(	NULL
Stratagene	NULL
)	NULL
containing	NULL
2	NULL
kilobase	NULL
pairs	NULL
of	NULL
IL-2	NULL
promoter	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
(	NULL
Macchia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

pSV2-CAT	NULL
is	NULL
described	NULL
in	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-CAT	NULL
was	NULL
described	NULL
in	NULL
Fan	NULL
and	NULL
Maniatis	NULL
(	NULL
1989	NULL
)	NULL
under	NULL
the	NULL
name	NULL
of	NULL
PRDIL	NULL
.	NULL

pSVT7	NULL
is	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
(	NULL
Bird	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

pSVT7/IL-1R	NULL
is	NULL
a	NULL
vector	NULL
expressing	NULL
the	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

pSVT7/hIL-1R	NULL
II	NULL
is	NULL
pSVT7	NULL
with	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
coding	NULL
sequences	NULL
,	NULL
cloned	NULL
in	NULL
the	NULL
correct	NULL
orientation	NULL
in	NULL
the	NULL
Sall	NULL
site	NULL
of	NULL
the	NULL
pSVT7	NULL
polylinker	NULL
.	NULL

The	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
cDNA	NULL
was	NULL
synthesized	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
as	NULL
follows	NULL
:	NULL
poly	NULL
(	NULL
A*	NULL
)	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
Raji	NULL
cells	NULL
,	NULL
subclone	NULL
1H7	NULL
(	NULL
Scapigliati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
first	NULL
strand	NULL
cDNA	NULL
synthesis	NULL
and	NULL
reverse	NULL
PCR	NULL
using	NULL
the	NULL
cDNA	NULL
cycle	NULL
kit	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
using	NULL
a	NULL
pair	NULL
of	NULL
amplimers	NULL
corresponding	NULL
to	NULL
the	NULL
first	NULL
8	NULL
codons	NULL
,	NULL
and	NULL
complementary	NULL
to	NULL
the	NULL
last	NULL
8	NULL
codons	NULL
(	NULL
including	NULL
the	NULL
stop	NULL
codon	NULL
)	NULL
of	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
cDNA	NULL
(	NULL
McMahan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
resulting	NULL
cDNA	NULL
containing	NULL
only	NULL
coding	NULL
sequences	NULL
plus	NULL
appropriate	NULL
restriction	NULL
sites	NULL
was	NULL
cloned	NULL
into	NULL
pSVT7	NULL
and	NULL
sequenced	NULL
.	NULL

All	NULL
plasmids	NULL
used	NULL
for	NULL
transfections	NULL
were	NULL
purified	NULL
using	NULL
the	NULL
Qiagen	NULL
Maxi-kit	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
Chimeric	NULL
Type	NULL
II/Type	NULL
I	NULL
IL-1R-A	NULL
portion	NULL
of	NULL
the	NULL
extracellular	NULL
region	NULL
and	NULL
the	NULL
transmembrane	NULL
region	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
were	NULL
synthesized	NULL
by	NULL
PCR	NULL
using	NULL
vent	NULL
DNA	NULL
polymerase	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
using	NULL
as	NULL
a	NULL
5'-amplimer	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
coding	NULL
sequences	NULL
around	NULL
the	NULL
Smal	NULL
site	NULL
at	NULL
nucleotide	NULL
position	NULL
916	NULL
in	NULL
the	NULL
cDNA	NULL
and	NULL
,	NULL
as	NULL
a	NULL
3'-amplimer	NULL
,	NULL
the	NULL
oligonucleotide	NULL
CAAGAA-3	NULL
'	NULL
,	NULL
corresponding	NULL
to	NULL
sequences	NULL
complementary	NULL
to	NULL
the	NULL
coding	NULL
strand	NULL
at	NULL
positions	NULL
1162-1137	NULL
(	NULL
McMahan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
introduced	NULL
a	NULL
Nde	NULL
!	NULL

site	NULL
by	NULL
changing	NULL
the	NULL
adenine	NULL
at	NULL
position	NULL
1160	NULL
in	NULL
the	NULL
cDNA	NULL
to	NULL
a	NULL
cytosine	NULL
.	NULL

This	NULL
base	NULL
substitution	NULL
did	NULL
not	NULL
change	NULL
the	NULL
amino	NULL
acid	NULL
encoded	NULL
by	NULL
the	NULL
triplet	NULL
.	NULL

Then	NULL
,	NULL
the	NULL
entire	NULL
intracellular	NULL
region	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
was	NULL
synthesized	NULL
by	NULL
PCR	NULL
using	NULL
vent	NULL
DNA	NULL
polymerase	NULL
using	NULL
as	NULL
a	NULL
5'-amplimer	NULL
the	NULL
oligonucleotide	NULL
TATGATGAAAATCTTCAAGATTGACATTGTG-3	NULL
'	NULL
,	NULL
where	NULL
the	NULL
first	NULL
13	NULL
bases	NULL
represent	NULL
type	NULL
II	NULL
IL-1R	NULL
sequences	NULL
(	NULL
including	NULL
the	NULL
substitution	NULL
to	NULL
create	NULL
an	NULL
Ndel	NULL
site	NULL
)	NULL
and	NULL
the	NULL
following	NULL
bases	NULL
correspond	NULL
to	NULL
type	NULL
I	NULL
IL-1R	NULL
coding	NULL
sequences	NULL
starting	NULL
from	NULL
the	NULL
first	NULL
codon	NULL
(	NULL
AAA	NULL
,	NULL
Lys	NULL
)	NULL
in	NULL
the	NULL
intracellular	NULL
domain	NULL
;	NULL
the	NULL
3'-amplimer	NULL
used	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
described	NULL
in	NULL
Heguy	NULL
et	NULL
al	NULL
(	NULL
1991	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
the	NULL
site	NULL
introduced	NULL
for	NULL
cloning	NULL
purposes	NULL
was	NULL
Xbal	NULL
and	NULL
not	NULL
Salil	NULL
.	NULL

The	NULL
resulting	NULL
type	NULL
II	NULL
and	NULL
type	NULL
I	NULL
amplified	NULL
fragments	NULL
were	NULL
restricted	NULL
with	NULL
SmaI/Ndel	NULL
and	NULL
Ndel/Xbal	NULL
,	NULL
respectively	NULL
,	NULL
purified	NULL
using	NULL
Geneclean	NULL
II	NULL
(	NULL
Bio	NULL
101	NULL
)	NULL
,	NULL
and	NULL
ligated	NULL
.	NULL

The	NULL
ligation	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
expected	NULL
size	NULL
of	NULL
ligated	NULL
type	NULL
II	NULL
and	NULL
type	NULL
I	NULL
IL-1R	NULL
fragments	NULL
was	NULL
cut	NULL
out	NULL
,	NULL
purified	NULL
with	NULL
Geneclean	NULL
II	NULL
,	NULL
and	NULL
,	NULL
subsequently	NULL
,	NULL
ligated	NULL
to	NULL
pGEM4Z	NULL
(	NULL
Stratagene	NULL
)	NULL
cut	NULL
with	NULL
Smal	NULL
and	NULL
Xbal	NULL
.	NULL

This	NULL
intermediate	NULL
construct	NULL
was	NULL
cut	NULL
with	NULL
EcoRI	NULL
and	NULL
Smal	NULL
and	NULL
used	NULL
as	NULL
a	NULL
vector	NULL
to	NULL
subclone	NULL
a	NULL
partial	NULL
EcoRI-complete	NULL
Smal	NULL
fragment	NULL
originated	NULL
by	NULL
digestion	NULL
of	NULL
pSVT7/hIL-1R	NULL
II	NULL
containing	NULL
the	NULL
coding	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
cDNA	NULL
from	NULL
the	NULL
ATG	NULL
codon	NULL
to	NULL
the	NULL
Smal	NULL
site	NULL
.	NULL

This	NULL
complete	NULL
chimeric	NULL
receptor	NULL
was	NULL
released	NULL
from	NULL
pGEM4Z	NULL
with	NULL
a	NULL
partial	NULL
EcoRI	NULL
digest	NULL
and	NULL
a	NULL
complete	NULL
Xbal	NULL
digest	NULL
and	NULL
cloned	NULL
into	NULL
pSVT7	NULL
between	NULL
the	NULL
EcoRI	NULL
and	NULL
Xbal	NULL
sites	NULL
of	NULL
its	NULL
polylinker	NULL
,	NULL
originating	NULL
the	NULL
expression	NULL
vector	NULL
pSVT7/hIL-1R	NULL
II/I	NULL
.	NULL

This	NULL
chimeric	NULL
cDNA	NULL
was	NULL
sequenced	NULL
to	NULL
confirm	NULL
its	NULL
identity	NULL
with	NULL
the	NULL
expected	NULL
sequences	NULL
and	NULL
to	NULL
exclude	NULL
PCR-introduced	NULL
errors	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
CAT	NULL
Assays-Jurkat	NULL
cells	NULL
(	NULL
Gillis	NULL
and	NULL
Watson	NULL
,	NULL
1980	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
12.5	NULL
aM	NULL
2-mercap-toethanol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Seromed	NULL
)	NULL
.	NULL

1	NULL
x	NULL
10	NULL
``	NULL
cells/sample	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
IL-1R-expressing	NULL
plasmids	NULL
and	NULL
5	NULL
ag	NULL
of	NULL
IL-2-CAT	NULL
reporter	NULL
plasmid	NULL
using	NULL
the	NULL
DEAE-	NULL
10491	NULL
dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Macchia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

When	NULL
pSV2-CAT	NULL
or	NULL
NF-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmids	NULL
were	NULL
used	NULL
,	NULL
the	NULL
procedure	NULL
was	NULL
scaled	NULL
down	NULL
to	NULL
one-tenth	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
24	NULL
h	NULL
,	NULL
split	NULL
into	NULL
equal	NULL
aliquots	NULL
,	NULL
and	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
Figs	NULL
.	NULL

2-4	NULL
for	NULL
8-12	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
0.25	NULL
M	NULL
Tris-HCl	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
;	NULL
CAT	NULL
enzyme	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
[	NULL
``	NULL
C	NULL
)	NULL
chloramphenicol	NULL
as	NULL
described	NULL
by	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
.	NULL

Autoradiographs	NULL
of	NULL
the	NULL
thin	NULL
layer	NULL
chromatograms	NULL
were	NULL
scanned	NULL
in	NULL
an	NULL
Ultrascan	NULL
XL	NULL
enhanced	NULL
laser	NULL
densitometer	NULL
.	NULL

RESULTS	NULL
The	NULL
human	NULL
lymphoma	NULL
Jurkat	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
detectable	NULL
amounts	NULL
of	NULL
IL-1Rs	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
Rosoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
expressing	NULL
either	NULL
the	NULL
murine	NULL
or	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
gain	NULL
responsiveness	NULL
to	NULL
IL-1	NULL
as	NULL
defined	NULL
by	NULL
induction	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
have	NULL
constructed	NULL
a	NULL
chimeric	NULL
cDNA	NULL
coding	NULL
for	NULL
a	NULL
hybrid	NULL
IL-1R	NULL
consisting	NULL
of	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
portions	NULL
of	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
(	NULL
McMahan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
fused	NULL
to	NULL
the	NULL
entire	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
transfected	NULL
this	NULL
chimeric	NULL
IL-1R	NULL
cloned	NULL
in	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
(	NULL
pSVT7/hIL-1R	NULL
II/I	NULL
)	NULL
and	NULL
compared	NULL
its	NULL
ability	NULL
to	NULL
mediate	NULL
activation	NULL
of	NULL
IL-1-responsive	NULL
promoters	NULL
with	NULL
that	NULL
of	NULL
the	NULL
type	NULL
I	NULL
or	NULL
type	NULL
II	NULL
IL-1Rs	NULL
.	NULL

A	NULL
construct	NULL
carrying	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
Jurkat	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
this	NULL
IL-2-CAT	NULL
construct	NULL
and	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
carrying	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
cDNA	NULL
(	NULL
pSVT7/hIL-1R	NULL
)	NULL
,	NULL
treatment	NULL
with	NULL
PHA	NULL
plus	NULL
IL-1	NULL
results	NULL
in	NULL
CAT	NULL
activity	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
PHA	NULL
plus	NULL
PMA	NULL
.	NULL

A	NULL
plasmid	NULL
expressing	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
cDNA	NULL
(	NULL
pSVT7/hIL-1R	NULL
II	NULL
)	NULL
failed	NULL
to	NULL
confer	NULL
IL-1-dependent	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
chimeric	NULL
type	NULL
II/type	NULL
I	NULL
IL-1R	NULL
construct	NULL
(	NULL
pSVT7/hIL-1R	NULL
II/I	NULL
)	NULL
with	NULL
the	NULL
IL-2-CAT	NULL
reporter	NULL
plasmid	NULL
resulted	NULL
in	NULL
an	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
PHA/IL-1	NULL
stimulation	NULL
comparable	NULL
with	NULL
that	NULL
mediated	NULL
by	NULL
the	NULL
wild-type	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
IL-2	NULL
reporter	NULL
plasmid	NULL
was	NULL
substituted	NULL
by	NULL
a	NULL
construct	NULL
coding	NULL
for	NULL
CAT	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
(	NULL
pSV2-CAT	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
the	NULL
SV40	NULL
promoter	NULL
responds	NULL
to	NULL
a	NULL
combination	NULL
of	NULL
IL-1	NULL
with	NULL
PMA	NULL
or	NULL
to	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

IL-1/PMA	NULL
costimulation	NULL
resulted	NULL
in	NULL
a	NULL
weak	NULL
induction	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
pSVT7	NULL
suggesting	NULL
that	NULL
Jurkat	NULL
cells	NULL
may	NULL
have	NULL
a	NULL
low	NULL
number	NULL
of	NULL
IL-1Rs	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
that	NULL
escape	NULL
detection	NULL
by	NULL
binding	NULL
or	NULL
IL-2-CAT	NULL
activity	NULL
assay	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
observations	NULL
of	NULL
IL-1-induced	NULL
release	NULL
of	NULL
diacylglycerol	NULL
from	NULL
phos-phatidylcholine	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
detectable	NULL
IL-1	NULL
binding	NULL
(	NULL
Rosoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
SV40-CAT	NULL
reporter	NULL
gene	NULL
with	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
construct	NULL
pSVT7/	NULL
IL-1R	NULL
II	NULL
resulted	NULL
in	NULL
a	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
comparable	NULL
with	NULL
the	NULL
control	NULL
pSVT7	NULL
plasmid	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
(	NULL
control	NULL
,	NULL
type	NULL
II	NULL
)	NULL
,	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
of	NULL
these	NULL
two	NULL
plasmids	NULL
,	NULL
the	NULL
CAT	NULL
activity	NULL
resulting	NULL
from	NULL
IL-1/PMA	NULL
stimulation	NULL
was	NULL
approximately	NULL
half	NULL
of	NULL
that	NULL
obtained	NULL
by	NULL
PHA/PMA	NULL
stimulation	NULL
.	NULL

In	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
expressing	NULL
construct	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-1/PMA	NULL
induction	NULL
of	NULL
SV40-CAT	NULL
activity	NULL
was	NULL
equivalent	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
PHA/PMA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
type	NULL
I	NULL
)	NULL
.	NULL

IL-1/PMA	NULL
treatment	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
expressing	NULL
the	NULL
chimeric	NULL
type	NULL
II/	NULL
type	NULL
I	NULL
sequences	NULL
resulted	NULL
in	NULL
a	NULL
level	NULL
of	NULL
SV40-driven	NULL
CAT	NULL
10492	NULL
aa	NULL
1	NULL
319	NULL
339	NULL
ma	NULL
Chimeric	NULL
Interleukin-1	NULL
Receptor	NULL
Signal	NULL
Transduction	NULL
552	NULL
IL-1R	NULL
(	NULL
type	NULL
1	NULL
)	NULL
IL-1R	NULL
(	NULL
type	NULL
11	NULL
)	NULL
type	NULL
II	NULL
/	NULL
1	NULL
Hybrid	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
IL-1Rs	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Top	NULL
,	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
;	NULL
middle	NULL
,	NULL
human	NULL
type	NULL
II	NULL
IL-1R	NULL
;	NULL
bottom	NULL
,	NULL
hybrid	NULL
type	NULL
II/type	NULL
I	NULL
receptors	NULL
.	NULL

The	NULL
numbers	NULL
indicate	NULL
amino	NULL
acid	NULL
positions	NULL
in	NULL
the	NULL
mature	NULL
protein	NULL
.	NULL

Boldface	NULL
numbers	NULL
represent	NULL
amino	NULL
acid	NULL
positions	NULL
in	NULL
the	NULL
mature	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
and	NULL
numbers	NULL
in	NULL
italics	NULL
represent	NULL
amino	NULL
acid	NULL
positions	NULL
in	NULL
the	NULL
mature	NULL
type	NULL
II	NULL
IL-1R	NULL
.	NULL

Horizontally	NULL
striped	NULL
boxes	NULL
represent	NULL
signal	NULL
peptide	NULL
sequences	NULL
,	NULL
the	NULL
open	NULL
bar	NULL
represents	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
stippled	NULL
boxes	NULL
represent	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
,	NULL
cross-hatched	NULL
boxes	NULL
represent	NULL
the	NULL
transmembrane	NULL
regions	NULL
of	NULL
both	NULL
the	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IL-1Rs	NULL
,	NULL
and	NULL
the	NULL
hatched	NULL
box	NULL
represents	NULL
the	NULL
short	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
.	NULL

PHA	NULL
+	NULL
IL-1	NULL
_	NULL
PMA	NULL
IL-1	NULL
_	NULL
PMA	NULL
IL-1	NULL
_	NULL
PMA	NULL
IL-1	NULL
_	NULL
PMA	NULL
«	NULL
amman	NULL
mar	NULL
move	NULL
moves	NULL
anns	NULL
Control	NULL
Type	NULL
I	NULL
Type	NULL
II	NULL
Type	NULL
II/	NULL
Hybrid	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
wild-type	NULL
and	NULL
hybrid	NULL
hIL-1R	NULL
function	NULL
on	NULL
IL-2	NULL
promoter	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Thin	NULL
layer	NULL
chromatograms	NULL
of	NULL
the	NULL
products	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
IL-2-CAT	NULL
construct	NULL
,	NULL
and	NULL
expression	NULL
vectors	NULL
containing	NULL
type	NULL
I	NULL
hIL-1R	NULL
,	NULL
type	NULL
II	NULL
hIL-1R	NULL
,	NULL
hybrid	NULL
type	NULL
II/type	NULL
I	NULL
IL-1Rs	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
or	NULL
vector	NULL
alone	NULL
(	NULL
control	NULL
)	NULL
.	NULL

Equal	NULL
aliquots	NULL
of	NULL
a	NULL
pool	NULL
of	NULL
cotransfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
plus	NULL
IL-1	NULL
(	NULL
IL-1-dependent	NULL
activation	NULL
)	NULL
or	NULL
PHA	NULL
plus	NULL
PMA	NULL
(	NULL
IL-1-independent	NULL
activation	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

activity	NULL
slightly	NULL
higher	NULL
than	NULL
that	NULL
induced	NULL
by	NULL
PHA/PMA	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
type	NULL
II/I	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
including	NULL
IL-1	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
reporter	NULL
plasmid	NULL
coding	NULL
for	NULL
CAT	NULL
under	NULL
the	NULL
control	NULL
of	NULL
an	NULL
artificial	NULL
NF-	NULL
«	NULL
B	NULL
promoter	NULL
transfected	NULL
into	NULL
the	NULL
murine	NULL
thy-moma	NULL
line	NULL
EL-4	NULL
responded	NULL
to	NULL
stimulation	NULL
by	NULL
IL-1	NULL
alone	NULL
without	NULL
the	NULL
need	NULL
for	NULL
a	NULL
costimulus	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-CAT	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
IL-1	NULL
alone	NULL
also	NULL
in	NULL
Jurkat	NULL
cells	NULL
cotransfected	NULL
with	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Baldari	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
IL-1	NULL
can	NULL
induce	NULL
NF-	NULL
«	NULL
B-CAT	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
type	NULL
II/type	NULL
I	NULL
IL-1R	NULL
.	NULL

A	NULL
low	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B-CAT	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
plasmid	NULL
pSVT7	NULL
or	NULL
pSVT7	NULL
expressing	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
control	NULL
,	NULL
type	NULL
II	NULL
)	NULL
,	NULL
although	NULL
this	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
is	NULL
about	NULL
one-fifth	NULL
of	NULL
that	NULL
resulting	NULL
from	NULL
PMA	NULL
treatment	NULL
,	NULL
which	NULL
represents	NULL
the	NULL
IL-1-independent	NULL
signal	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

In	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
a	NULL
vector	NULL
expressing	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-1-induced	NULL
CAT	NULL
activity	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
that	NULL
obtained	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
type	NULL
I	NULL
)	NULL
indicating	NULL
that	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
IL-1	NULL
signal	NULL
must	NULL
be	NULL
transmitted	NULL
by	NULL
its	NULL
receptor	NULL
to	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
hybrid	NULL
type	NULL
II/type	NULL
I	NULL
IL-1R	NULL
consistently	NULL
resulted	NULL
in	NULL
a	NULL
1.3-1.5-fold	NULL
higher	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
than	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
.	NULL

This	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
shows	NULL
a	NULL
higher	NULL
binding	NULL
capacity	NULL
for	NULL
IL-1	NULL
,	NULL
which	NULL
was	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
than	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Scapigliati	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

IL-1ra	NULL
competitively	NULL
inhibits	NULL
binding	NULL
of	NULL
IL-18	NULL
to	NULL
both	NULL
the	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
receptors	NULL
(	NULL
Hannum	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Eisenberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
,	NULL
1991	NULL
;	NULL
Granowitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Dripps	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
were	NULL
interested	NULL
in	NULL
what	NULL
effect	NULL
the	NULL
IL-1ra	NULL
would	NULL
have	NULL
on	NULL
IL-1	NULL
activation	NULL
mediated	NULL
by	NULL
the	NULL
chimeric	NULL
receptor	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
shows	NULL
the	NULL
effect	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
IL-1ra	NULL
on	NULL
IL-18	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
promoter	NULL
mediated	NULL
by	NULL
the	NULL
type	NULL
I	NULL
receptor	NULL
and	NULL
the	NULL
chimeric	NULL
receptor	NULL
.	NULL

For	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
chose	NULL
a	NULL
concentration	NULL
of	NULL
3	NULL
pM	NULL
IL-13	NULL
,	NULL
which	NULL
is	NULL
approximately	NULL
5	NULL
times	NULL
the	NULL
concentration	NULL
required	NULL
for	NULL
half-maximal	NULL
activation	NULL
in	NULL
this	NULL
system	NULL
.	NULL
``	NULL

IL-1ra	NULL
was	NULL
considerably	NULL
more	NULL
potent	NULL
in	NULL
inhibiting	NULL
type	NULL
I	NULL
IL-1R-mediated	NULL
than	NULL
chimer-mediated	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
promoter	NULL
.	NULL

In	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
IL-ira	NULL
inhibited	NULL
50	NULL
%	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-CAT	NULL
construct	NULL
by	NULL
3	NULL
pM	NULL
IL-18	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
approximately	NULL
7	NULL
nM	NULL
,	NULL
whereas	NULL
a	NULL
concentration	NULL
of	NULL
approximately	NULL
60	NULL
nM	NULL
was	NULL
required	NULL
to	NULL
inhibit	NULL
50	NULL
%	NULL
of	NULL
type	NULL
II/type	NULL
I-mediated	NULL
activation	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
potency	NULL
reflects	NULL
the	NULL
relative	NULL
affinities	NULL
of	NULL
IL-18	NULL
and	NULL
IL-lra	NULL
for	NULL
the	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
receptors	NULL
(	NULL
reviewed	NULL
in	NULL
Dinarello	NULL
and	NULL
Thompson	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
chimeric	NULL
type	NULL
II/type	NULL
I	NULL
receptor	NULL
transduces	NULL
signals	NULL
indistinguishable	NULL
from	NULL
the	NULL
type	NULL
I	NULL
receptor	NULL
,	NULL
it	NULL
retains	NULL
relative	NULL
binding	NULL
affinities	NULL
for	NULL
and	NULL
IL-1ra	NULL
similar	NULL
to	NULL
the	NULL
type	NULL
II	NULL
receptor	NULL
.	NULL

DISCUSSION	NULL
The	NULL
use	NULL
of	NULL
chimeric	NULL
receptors	NULL
has	NULL
proven	NULL
to	NULL
be	NULL
an	NULL
excellent	NULL
tool	NULL
to	NULL
study	NULL
the	NULL
mechanisms	NULL
of	NULL
signaling	NULL
of	NULL
receptors	NULL
that	NULL
have	NULL
not	NULL
been	NULL
well	NULL
characterized	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
experiments	NULL
with	NULL
a	NULL
number	NULL
of	NULL
chimeric	NULL
growth	NULL
factor	NULL
receptors	NULL
belonging	NULL
to	NULL
the	NULL
tyrosine	NULL
kinase	NULL
family	NULL
have	NULL
shown	NULL
that	NULL
these	NULL
receptors	NULL
employ	NULL
an	NULL
identical	NULL
mechanism	NULL
for	NULL
signal	NULL
transduction	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
Riedel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Lehvaslaiho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Lev	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
some	NULL
other	NULL
cases	NULL
,	NULL
chimeric	NULL
molecules	NULL
were	NULL
constructed	NULL
between	NULL
receptors	NULL
belonging	NULL
to	NULL
different	NULL
classes	NULL
,	NULL
and	NULL
signal	NULL
transduction	NULL
was	NULL
or	NULL
was	NULL
not	NULL
observed	NULL
,	NULL
according	NULL
to	NULL
the	NULL
hybrid	NULL
constructed	NULL
.	NULL

The	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
kinase	NULL
was	NULL
not	NULL
stimulated	NULL
in	NULL
cells	NULL
expressing	NULL
an	NULL
IL-2R-epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
hybrid	NULL
(	NULL
Bernard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
chimeric	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor-nerve	NULL
growth	NULL
factor	NULL
receptor	NULL
mediated	NULL
nuclear	NULL
signaling	NULL
in	NULL
nerve	NULL
growth	NULL
factor-responsive	NULL
cells	NULL
(	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
a	NULL
hybrid	NULL
molecule	NULL
of	NULL
two	NULL
receptors	NULL
,	NULL
which	NULL
presumably	NULL
have	NULL
different	NULL
intracellular	NULL
mechanisms	NULL
of	NULL
signaling	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
signal	NULL
transduction	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
,	NULL
furthermore	NULL
,	NULL
it	NULL
can	NULL
mediate	NULL
nuclear	NULL
signaling	NULL
.	NULL

We	NULL
show	NULL
that	NULL
,	NULL
although	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
failed	NULL
to	NULL
mediate	NULL
IL-1	NULL
responses	NULL
,	NULL
a	NULL
chimeric	NULL
IL-1	NULL
receptor	NULL
composed	NULL
of	NULL
the	NULL
>	NULL
C.	NULL
T.	NULL
Baldari	NULL
and	NULL
J.	NULL
L.	NULL
Telford	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

Chimeric	NULL
Interleukin-1	NULL
Receptor	NULL
Signal	NULL
Transduction	NULL
1,57	NULL
SV40	NULL
<	NULL
p3	NULL
9	NULL
1,07	NULL
<	NULL
I	NULL
o	NULL
.	NULL

~	NULL
=	NULL
0,5	NULL
,	NULL
<	NULL
Ce	NULL
0,0	NULL
Control	NULL
Type	NULL
!	NULL

Type	NULL
I	NULL
!	NULL

Type	NULL
IM	NULL
B	NULL
1157	NULL
|	NULL
NF	NULL
-	NULL
kB	NULL
1,0	NULL
<	NULL
3	NULL
a	NULL
.	NULL

~	NULL
-	NULL
4	NULL
3	NULL
0,5	NULL
0,0	NULL
4	NULL
Control	NULL
Type	NULL
!	NULL

Type	NULL
II	NULL
Type	NULL
I/	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Analysis	NULL
of	NULL
wild-type	NULL
and	NULL
hybrid	NULL
hIL-1Rs	NULL
on	NULL
SV40	NULL
promoter	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
artificial	NULL
promoter	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
comparison	NULL
of	NULL
CAT	NULL
activities	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
cotransfected	NULL
with	NULL
an	NULL
SV40-CAT	NULL
reporter	NULL
plasmid	NULL
and	NULL
either	NULL
wild-type	NULL
or	NULL
hybrid	NULL
hIL-1Rs	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
histogram	NULL
bars	NULL
represent	NULL
the	NULL
ratio	NULL
between	NULL
CAT	NULL
activity	NULL
obtained	NULL
with	NULL
IL-1/PMA	NULL
costimulation	NULL
and	NULL
CAT	NULL
activity	NULL
resulting	NULL
from	NULL
the	NULL
IL-1-independent	NULL
stimulation	NULL
,	NULL
PHA/	NULL
PMA	NULL
.	NULL

Each	NULL
experimental	NULL
point	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
other	NULL
experiments	NULL
that	NULL
gave	NULL
similar	NULL
values	NULL
.	NULL

B	NULL
,	NULL
comparison	NULL
of	NULL
CAT	NULL
activities	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
cotransfected	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-CAT	NULL
construct	NULL
and	NULL
wild-type	NULL
or	NULL
hybrid	NULL
IL-1Rs	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
histogram	NULL
bars	NULL
represent	NULL
the	NULL
ratio	NULL
between	NULL
CAT	NULL
activities	NULL
obtained	NULL
with	NULL
IL-1	NULL
stimulation	NULL
and	NULL
CAT	NULL
activities	NULL
obtained	NULL
with	NULL
PMA	NULL
stimulation	NULL
.	NULL

Each	NULL
point	NULL
was	NULL
done	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
other	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Note	NULL
that	NULL
IL-1	NULL
is	NULL
capable	NULL
of	NULL
weakly	NULL
stimulating	NULL
these	NULL
two	NULL
promoters	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
functional	NULL
IL-1R	NULL
.	NULL

extracellular	NULL
and	NULL
transmembrane	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
type	NULL
II	NULL
IL-1	NULL
receptor	NULL
fused	NULL
to	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
the	NULL
human	NULL
type	NULL
I	NULL
IL-1R	NULL
is	NULL
capable	NULL
of	NULL
transducing	NULL
the	NULL
IL-1	NULL
signal	NULL
across	NULL
the	NULL
membrane	NULL
and	NULL
triggering	NULL
IL-1-mediated	NULL
gene	NULL
activation	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
signal	NULL
delivered	NULL
by	NULL
the	NULL
chimeric	NULL
receptor	NULL
was	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
in	NULL
that	NULL
it	NULL
10493	NULL
-D-	NULL
Type	NULL
1	NULL
120	NULL
-K-	NULL
Type	NULL
II/I	NULL
100	NULL
80	NULL
7	NULL
60	NULL
CAT	NULL
Activity	NULL
40	NULL
{	NULL
20	NULL
00	NULL
0	NULL
p	NULL
-	NULL
--	NULL
10	NULL
100	NULL
1000	NULL
IL-tra	NULL
(	NULL
nM	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
IL-lra	NULL
on	NULL
type	NULL
I-	NULL
and	NULL
chimeric	NULL
IL-1R-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B-CAT	NULL
.	NULL

Aliquots	NULL
of	NULL
a	NULL
single	NULL
pool	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-CAT	NULL
construct	NULL
and	NULL
either	NULL
the	NULL
type	NULL
I	NULL
or	NULL
chimeric	NULL
IL-1Rs	NULL
were	NULL
activated	NULL
with	NULL
3	NULL
pM	NULL
IL-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
IL-1ra	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
normalized	NULL
relative	NULL
to	NULL
the	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-1ra	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
show	NULL
standard	NULL
deviation	NULL
,	NULL
IL-1ra	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
nM	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-CAT	NULL
construct	NULL
by	NULL
PMA	NULL
.	NULL

synergized	NULL
with	NULL
PHA	NULL
in	NULL
IL-2	NULL
promoter	NULL
activation	NULL
and	NULL
with	NULL
PMA	NULL
in	NULL
SV40	NULL
promoter	NULL
activation	NULL
,	NULL
and	NULL
stimulated	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
artificial	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
stimuli	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
the	NULL
type	NULL
II	NULL
receptor	NULL
to	NULL
mediate	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
could	NULL
reflect	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
role	NULL
in	NULL
IL-1	NULL
signal	NULL
transduction	NULL
,	NULL
but	NULL
it	NULL
could	NULL
also	NULL
be	NULL
possible	NULL
that	NULL
these	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
additional	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
second	NULL
chains	NULL
,	NULL
which	NULL
could	NULL
be	NULL
needed	NULL
for	NULL
type	NULL
II	NULL
IL-1R-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

The	NULL
question	NULL
of	NULL
IL-1R	NULL
activation	NULL
is	NULL
inevitably	NULL
linked	NULL
to	NULL
the	NULL
functional	NULL
binding	NULL
of	NULL
IL-1	NULL
.	NULL

Two	NULL
out	NULL
of	NULL
three	NULL
polypeptides	NULL
(	NULL
IL-la	NULL
and	NULL
IL-1	NULL
)	NULL
that	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
the	NULL
type	NULL
I	NULL
and	NULL
the	NULL
type	NULL
II	NULL
IL-1Rs	NULL
are	NULL
capable	NULL
of	NULL
transducing	NULL
a	NULL
signal	NULL
resulting	NULL
in	NULL
a	NULL
biological	NULL
effect	NULL
of	NULL
IL-1	NULL
,	NULL
while	NULL
the	NULL
third	NULL
member	NULL
of	NULL
the	NULL
IL-1	NULL
family	NULL
,	NULL
the	NULL
receptor	NULL
antagonist	NULL
polypeptide	NULL
IL-1ra	NULL
,	NULL
can	NULL
bind	NULL
to	NULL
both	NULL
types	NULL
of	NULL
IL-1Rs	NULL
(	NULL
Hannum	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Eisenberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
,	NULL
1991	NULL
;	NULL
Granowitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Dripps	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
but	NULL
does	NULL
not	NULL
become	NULL
internalized	NULL
,	NULL
does	NULL
not	NULL
elicit	NULL
cellular	NULL
responses	NULL
,	NULL
and	NULL
blocks	NULL
the	NULL
effects	NULL
of	NULL
IL-l	NULL
«	NULL
and	NULL
IL-18	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Dinarello	NULL
and	NULL
Thompson	NULL
(	NULL
1991	NULL
)	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
substitution	NULL
in	NULL
the	NULL
IL-1lra	NULL
converts	NULL
it	NULL
to	NULL
an	NULL
agonist	NULL
(	NULL
Ju	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
that	NULL
a	NULL
single	NULL
substitution	NULL
in	NULL
IL-1	NULL
causes	NULL
loss	NULL
of	NULL
function	NULL
but	NULL
not	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
(	NULL
Gehrke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
binding	NULL
per	NULL
se	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
trigger	NULL
the	NULL
IL-1R	NULL
and	NULL
that	NULL
there	NULL
are	NULL
two	NULL
types	NULL
of	NULL
binding	NULL
,	NULL
functional	NULL
and	NULL
nonfunctional	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
functional	NULL
binding	NULL
,	NULL
capable	NULL
of	NULL
triggering	NULL
signal	NULL
transduction	NULL
,	NULL
remains	NULL
obscure	NULL
.	NULL

It	NULL
could	NULL
be	NULL
speculated	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
certain	NULL
structure	NULL
in	NULL
the	NULL
IL-1	NULL
ligand-receptor	NULL
complex	NULL
is	NULL
needed	NULL
for	NULL
transduction	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
form	NULL
both	NULL
a	NULL
functional	NULL
complex	NULL
with	NULL
IL-18	NULL
and	NULL
a	NULL
nonfunctional	NULL
complex	NULL
with	NULL
IL-1ra	NULL
.	NULL

Although	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
has	NULL
been	NULL
well	NULL
characterized	NULL
10494	NULL
functionally	NULL
,	NULL
the	NULL
biological	NULL
relevance	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
is	NULL
still	NULL
poorly	NULL
understood	NULL
.	NULL

The	NULL
type	NULL
I	NULL
IL-1R	NULL
is	NULL
a	NULL
signaling	NULL
mol-ecule	NULL
,	NULL
and	NULL
transduction	NULL
is	NULL
dependent	NULL
on	NULL
functional	NULL
IL-1	NULL
binding	NULL
and	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
cytolasmic	NULL
domain	NULL
(	NULL
Curtis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Heguy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

There	NULL
is	NULL
some	NULL
controversy	NULL
as	NULL
to	NULL
whether	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
is	NULL
a	NULL
signaling	NULL
molecule	NULL
or	NULL
a	NULL
regulatory	NULL
molecule	NULL
.	NULL

Some	NULL
studies	NULL
suggest	NULL
that	NULL
it	NULL
mediates	NULL
some	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
IL-1	NULL
on	NULL
lymphocytes	NULL
,	NULL
bone	NULL
marrow	NULL
cells	NULL
,	NULL
brain	NULL
,	NULL
and	NULL
the	NULL
development	NULL
of	NULL
endotoxin-induced	NULL
shock	NULL
.	NULL
``	NULL

Other	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
may	NULL
not	NULL
be	NULL
involved	NULL
in	NULL
delivering	NULL
biological	NULL
signals	NULL
in	NULL
response	NULL
to	NULL
IL-1	NULL
because	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
does	NULL
not	NULL
block	NULL
IL-1-mediated	NULL
IL-8	NULL
induction	NULL
in	NULL
THP	NULL
or	NULL
HepG2	NULL
cells	NULL
nor	NULL
does	NULL
it	NULL
block	NULL
induction	NULL
of	NULL
a	NULL
«	NULL
l-acid	NULL
glycoprotein	NULL
or	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
HepG2	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
all	NULL
of	NULL
these	NULL
responses	NULL
are	NULL
blocked	NULL
by	NULL
anti-type	NULL
I	NULL
IL-1R	NULL
anti-bodies	NULL
.	NULL

*	NULL
Our	NULL
chimeric	NULL
receptor	NULL
clearly	NULL
demonstrates	NULL
that	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
is	NULL
not	NULL
only	NULL
capable	NULL
of	NULL
functionally	NULL
binding	NULL
IL-1	NULL
but	NULL
it	NULL
can	NULL
also	NULL
signal	NULL
across	NULL
the	NULL
membrane	NULL
to	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
.	NULL

This	NULL
result	NULL
does	NULL
not	NULL
prove	NULL
that	NULL
the	NULL
type	NULL
II	NULL
IL-1R	NULL
mediates	NULL
biological	NULL
responses	NULL
to	NULL
IL-1	NULL
,	NULL
but	NULL
it	NULL
suggests	NULL
that	NULL
such	NULL
a	NULL
function	NULL
is	NULL
possible	NULL
,	NULL
at	NULL
least	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
our	NULL
results	NULL
can	NULL
also	NULL
be	NULL
interpreted	NULL
as	NULL
an	NULL
indication	NULL
that	NULL
IL-1-mediated	NULL
gene	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
type	NULL
I	NULL
IL-1R	NULL
,	NULL
independent	NULL
of	NULL
the	NULL
type	NULL
of	NULL
extracellular	NULL
ligand	NULL
binding	NULL
por-tion	NULL
.	NULL

Ultimately	NULL
,	NULL
the	NULL
question	NULL
of	NULL
IL-1	NULL
signal	NULL
transduction	NULL
will	NULL
be	NULL
resolved	NULL
once	NULL
the	NULL
intermediate	NULL
intracellular	NULL
messengers	NULL
that	NULL
interact	NULL
with	NULL
IL-1Rs	NULL
are	NULL
identified	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
John	NULL
Sims	NULL
for	NULL
sharing	NULL
unpublished	NULL
data	NULL
and	NULL
Giorgio	NULL
Corsi	NULL
for	NULL
artwork	NULL
.	NULL

REFERENCES	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Melli	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

226	NULL
,	NULL
19103-19108	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1992a	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
4289-4291	NULL
Baldari	NULL
,	NULL
C	NULL
T	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
Massone	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1992b	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

304	NULL
,	NULL
2	NULL
~364	NULL
Bernard	NULL
0	NULL
Fazekas	NULL
de	NULL
St.	NULL
Groth	NULL
,	NULL
B.	NULL
,	NULL
Ullrich	NULL
,	NULL
A.	NULL
,	NULL
Green	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

$	NULL
,	NULL
A	NULL
.	NULL

84	NULL
,	NULL
2125-2129	NULL
.	NULL

Bird	NULL
,	NULL
P.	NULL
,	NULL
Gething	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

105	NULL
,	NULL
2905-2914	NULL
P.	NULL
Ghiara	NULL
,	NULL
D.	NULL
Armellini	NULL
,	NULL
G.	NULL
Scapigliati	NULL
,	NULL
S.	NULL
Nuti	NULL
,	NULL
D.	NULL
Nucci	NULL
,	NULL
M.	NULL
Bugnoli	NULL
,	NULL
L.	NULL
Villa	NULL
,	NULL
A.	NULL
Tagliabue	NULL
,	NULL
and	NULL
D.	NULL
Boraschi	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

*J.	NULL
Sims	NULL
,	NULL
personal	NULL
communication	NULL
.	NULL

Chimeric	NULL
Interleukin-1	NULL
Receptor	NULL
Signal	NULL
Transduction	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
135-	NULL
140	NULL
Casagli	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Borri	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
D'Ettorre	NULL
,	NULL
C.	NULL
,	NULL
Galeotti	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
DiLiegro	NULL
,	NULL
C.	NULL
,	NULL
Ghiara	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Antoni	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Prep	NULL
.	NULL

Biochem	NULL
.	NULL

19	NULL
,	NULL
23-25	NULL
Curtis	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Gallis	NULL
,	NULL
B.	NULL
,	NULL
Overell	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
McMahan	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
deRoos	NULL
,	NULL
P.	NULL
,	NULL
Ireland	NULL
,	NULL
R.	NULL
,	NULL
Eisenman	NULL
,	NULL
J.	NULL
,	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
3045-3049	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1627-1652	NULL
Dmarello	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
12	NULL
,	NULL
404-410	NULL
Dripps	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Verderber	NULL
,	NULL
E.	NULL
,	NULL
Ng	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Elsenberg	NULL
,	NULL
S	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
20311	NULL
20315	NULL
Eisenberg	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Evans	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Arend	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
Verderber	NULL
,	NULL
E.	NULL
,	NULL
Brewer	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Hannum	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
348	NULL
,	NULL
341-346	NULL
Eisenberg	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Brewer	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Verderber	NULL
,	NULL
E.	NULL
,	NULL
Heimdal	NULL
,	NULL
P.	NULL
,	NULL
Brandhyber	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
5232-5236	NULL
Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
101-110	NULL
Gay	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
and	NULL
Keith	NULL
,	NULL
F.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
351	NULL
,	NULL
355-356	NULL
Gehrke	NULL
,	NULL
L.	NULL
,	NULL
Jobling	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Paik	NULL
,	NULL
L.	NULL
S.	NULL
K.	NULL
,	NULL
McDonald	NULL
,	NULL
B.	NULL
,	NULL
Rosenwasser	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Auron	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
5922-5925	NULL
Gillis	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Watson	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

152	NULL
,	NULL
1709-1719	NULL
Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Kincade	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
and	NULL
Mizel	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

132	NULL
,	NULL
223-228	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Granowitz	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
Mancilla	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14147-14150	NULL
Hannum	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Wilcox	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Arend	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
Joslin	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Dripps	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Heimdal	NULL
,	NULL
L.	NULL
,	NULL
Armes	NULL
,	NULL
L.	NULL
G.	NULL
,	NULL
Sommer	NULL
,	NULL
A.	NULL
,	NULL
Eisenberg	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
348	NULL
,	NULL
336-340	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Tsudo	NULL
,	NULL
M.	NULL
,	NULL
Minamoto	NULL
,	NULL
S.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
Miyasaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Tamguchl	NULL
,	NULL
T.	NULL
(	NULL
19892	NULL
)	NULL
Science	NULL
244	NULL
551-556	NULL
Hatakeyama	NULL
,	NULL
M	NULL
Mori	NULL
,	NULL
H	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tanigichi	NULL
,	NULL
T.	NULL
(	NULL
1989b	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
837-845	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Baldan	NULL
C.	NULL
T.	NULL
,	NULL
Bush	NULL
,	NULL
K	NULL
Nagele	NULL
,	NULL
R.	NULL
,	NULL
Newton	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Robb	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Horuk	NULL
,	NULL
R	NULL
Telford	NULL
J.	NULL
L	NULL
and	NULL
Melh	NULL
,	NULL
M	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
thfer	NULL
2	NULL
311-315	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Melli	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
2605-2609	NULL
Horuk	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
McCubrey	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

260	NULL
,	NULL
657-663	NULL
Ju	NULL
,	NULL
G.	NULL
,	NULL
Labrxola	NULL
Tompkins	NULL
,	NULL
E.	NULL
,	NULL
Campen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Benjamin	NULL
W.	NULL
R.	NULL
,	NULL
Karas	NULL
,	NULL
J.	NULL
,	NULL
Plocmsk1	NULL
.	NULL

,	NULL
Biondi	NULL
,	NULL
D.	NULL
,	NULL
Kaffka	NULL
K.	NULL
L.	NULL
,	NULL
than	NULL
P.	NULL
L.	NULL
,	NULL
Elsenberg	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
'	NULL
A	NULL
.	NULL

88	NULL
,	NULL
2658-2662	NULL
Lee	NULL
,	NULL
J.	NULL
,	NULL
Dull	NULL
T.	NULL
J.	NULL
,	NULL
Lax	NULL
,	NULL
I.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ullrich	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
167	NULL
173	NULL
Lehvaslaiho	NULL
,	NULL
H.	NULL
,	NULL
Lethola	NULL
,	NULL
L.	NULL
,	NULL
Sistonen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
159-166	NULL
Lev	NULL
,	NULL
S.	NULL
,	NULL
Yarden	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Givol	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
6064-6068	NULL
Macchia	NULL
,	NULL
G.	NULL
,	NULL
Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Massone	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Telford	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2731-2737	NULL
McMahan	NULL
,	NULL
C	NULL
J.	NULL
,	NULL
Slack	NULL
,	NULL
L.	NULL
,	NULL
Mosley	NULL
,	NULL
B.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Lupton	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Brunton	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Grubin	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
ngnall	NULL
J.	NULL
M.	NULL
,	NULL
Jenkms	NULL
,	NULL
N.	NULL
A	NULL
Brannan	NULL
,	NULL
C.	NULL
I	NULL
Copeland	NULL
N.	NULL
G.	NULL
,	NULL
Huebner	NULL
,	NULL
K	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Cannizaro	NULL
,	NULL
L.	NULL
A	NULL
Benjamin	NULL
,	NULL
D	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Spng	NULL
s	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
'and	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2821-	NULL
2832	NULL
Nncola	NULL
N.	NULL
i	NULL
and	NULL
Metcalf	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
1-4	NULL
Rledel	NULL
H.	NULL
,	NULL
Dull	NULL
T.	NULL
J.	NULL
,	NULL
SchlessmgenJ	NULL
and	NULL
Ullrlch	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
324	NULL
,	NULL
68-	NULL
Rosoff	NULL
P.	NULL
M.	NULL
,	NULL
Savage	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
73-81	NULL
Scapi	NULL
llat1	NULL
,	NULL
G	NULL
Ghiara	NULL
,	NULL
P.	NULL
,	NULL
,	NULL
Bartalini	NULL
,	NULL
M.	NULL
,	NULL
Taghabue	NULL
A.	NULL
,	NULL
and	NULL
Borasch1	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

243	NULL
,	NULL
394-398	NULL
Scapigliati	NULL
,	NULL
G.	NULL
,	NULL
Bossu	NULL
,	NULL
P.	NULL
,	NULL
Censini	NULL
,	NULL
S.	NULL
,	NULL
Tagliabue	NULL
,	NULL
A.	NULL
,	NULL
Boraschi	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Ghiara	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
188	NULL
,	NULL
31-38	NULL
Schneider	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Hudson	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Lin	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
K.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
197-807	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
Widmer	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
McDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
McMahan	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Wignall	NULL
J.	NULL
M.	NULL
,	NULL
Jackson	NULL
J.	NULL
L	NULL
Call	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Fnend	NULL
D.	NULL
,	NULL
Alpert	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Gillis	NULL
,	NULL
S.	NULL
,	NULL
Urdal	NULL
,	NULL
D	NULL
.	NULL
'	NULL

L.	NULL
,	NULL
and	NULL
Dower	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
585-589	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Acres	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Grubin	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
McMahan	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Wxgnall	NULL
J.	NULL
M.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
J	NULL
and	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
8946-8950	NULL
Ullrlch	NULL
A.	NULL
,	NULL
and	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
203-212	NULL
Yan	NULL
,	NULL
H	NULL
Schlessmger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Chao	NULL
,	NULL
M.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
561-563	NULL

